RxCentric Ramps Up Operations And Sales Management To Accelerate Continued Business Expansion.
NEW YORK--(BUSINESS WIRE)--Feb. 27, 2001
RxCentric Inc., a leading Internet Marketing Solutions Provider to the pharmaceutical industry linking physicians' drug information and educational needs with targeted online pharmaceutical product-marketing capability, announced today that Michael J. Wise, a former consultant to the pharmaceutical industry with international management consulting firm A.T. Kearney, has joined as Executive Vice President of Operations.
RxCentric also announced the appointment of Rick Stefany, an experienced sales executive who has developed major national account relationships with several of the world's leading pharmaceutical companies, as Senior Vice President of Sales.
Both Wise and Stefany will complement RxCentric's existing senior management team and will focus on developing and managing strategic commercial relationships with large pharmaceutical firms, capitalizing on RxCentric's expanding physician user base and Internet-based product offerings.
"With our technical internet service delivery platform now refined and with our proven ability to develop communities of physician users, Wise and Stefany will accelerate our contracting of online promotional programs with pharmaceutical company partners," said Richard Findlay, RxCentric's President and Chief Executive Officer.
Wise is an accomplished manager with demonstrated success in business development and project management roles. At A. T. Kearney, he served many of the world's largest pharmaceutical companies, leading teams addressing key issues ranging from R&D strategy to profit maximization. Wise also served as a market research analyst and product manager at AstraZeneca Pharmaceuticals.
Stefany has extensive experience in the areas of pharmaceutical marketing, business development, sales and general management. He has held senior sales positions with such companies as SciQuest.com, and VWR Scientific Products, Inc., where he negotiated long-term partnerships at senior levels with companies such as Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., Genzyme Corporation and Roche, Inc, among others.
RxCentric provides physicians customized information in seven targeted medical specialties through its free, physician-only ISP, Doctors Net Access (DNA): Allergy, Cardiology, Neurology, Oncology/Hematology, Primary Care, Pulmonary Medicine and Urology.
Since its founding, RxCentric has built internally a portfolio of products and services to extend pharmaceutical-company communication with targeted physicians. RxCentric's online portfolio of products and services includes detailing, sampling, continuing medical education, events, market research, proprietary drug search engine, sales representative support and informatics.
RxCentric is a privately held company with locations in New York, Morristown N.J., Philadelphia, Chicago and San Diego.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 27, 2001|
|Previous Article:||U.S. Cellular Launches Wireless Road Rules Campaign; Wireless Carrier Encourages Driving Safety.|
|Next Article:||Qatar Airways Places $120 Million CF6-80E1 Order for New Airbus A330 Fleet.|